Data from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
CD36
Scavenger Receptor
DOI:
10.1158/0008-5472.c.6816237.v1
Publication Date:
2023-09-01T08:55:50Z
AUTHORS (31)
ABSTRACT
<div>Abstract<p>Identifying mechanisms underlying relapse is a major clinical issue for effective cancer treatment. The emerging understanding of the importance metastasis in hematologic malignancies suggests that it could also play role drug resistance and acute myeloid leukemia (AML). In cohort 1,273 AML patients, we uncovered multifunctional scavenger receptor CD36 was positively associated with extramedullary dissemination leukemic blasts, increased risk after intensive chemotherapy, reduced event-free overall survival. dispensable lipid uptake but fostered blast migration through its binding thrombospondin-1. CD36-expressing which were largely enriched exhibited senescent-like phenotype while maintaining their migratory ability. xenograft mouse models, inhibition blasts prolonged survival chemotherapy-treated mice. These results pave way development as an independent marker poor prognosis patients promising actionable target to improve outcome patients.</p>Significance:<p>CD36 promotes disease represents critical can be exploited patient treatment.</p></div>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....